The Pharmaletter
One To Watch
DiCE Molecules
DiCE Molecules is a privately held biotechnology company using directed evolution to power small molecule drug discovery.
DiCE was co-founded in 2013 by Pehr Harbury, the investor of the firm's core technology, Kevin Judice and Phil Patten.
Latest DiCE Molecules News
11 January 2021
20 December 2017
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze